Isoquinoline potassium channel inhibitors

Details for Australian Patent Application No. 2004275720 (hide)

Owner Merck & Co., Inc.

Inventors Nanda, Kausik K.; Claremon, David A.; Kett, Nathan R.; Trotter, B. Wesley; Ponticello, Gerald S.; Dinsmore, Christopher J.

Agent Spruson & Ferguson

Pub. Number AU-B-2004275720

PCT Pub. Number WO2005/030130

Priority 60/505,143 23.09.03 US

Filing date 17 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 24 April 2008

International Classifications

C07D 217/14 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 217/16 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/030130 Priority application(s): WO2005/030130

24 April 2008 Application Accepted

  Published as AU-B-2004275720

21 August 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275727-Fluid delivery device identification and loading system

2004275719-Quinoline potassium channel inhibitors